Atherosclerosis & Cardiovascular Therapies

Stanford's Program for Atherosclerosis and Cardiovascular Therapies (PACT) uses an integrated approach of aggressive behavioral and medical therapy for patients with established cardiovascular disease and those who have modifiable risk factors for cardiovascular or cerebrovascular events such as stroke. This program is an expansion of the Stanford Preventive Cardiology Clinic, which was established nearly 30 years ago.

Recent clinical trials have demonstrated that reducing cholesterol levels prevents cardiovascular disease and lowers total mortality. Other studies, using multiple research methods over several decades, confirm the evidence linking risk factors and cardiovascular disease. Angiographic and functional studies in atherosclerosis show that aggressive risk-factor modification retards the progression of vascular disease and stabilizes vulnerable plaque. Comprehensive risk assessment and therapy is now recognized as an integral part of care for patients with cardiovascular disease and those at high risk.

Program Goals

There is a large population of at-risk patients who currently do not have access to the clinical resources for optimal management of the factors that promote cardiovascular diseases. The goal of PACT is to comprehensively evaluate these patients and to provide them with the most effective measures to impede the progression of atherosclerosis. We explore multiple treatment methods for every patient to determine the optimal approach. Patients also have access to research protocols and clinical trials.

Program Highlights

The program is designed for people who have a history of heart disease, are at risk for heart disease, or simply want to know their risk for future cardiovascular events. The services available include:

Stanford Medicine Resources:

Footer Links: